Optical Devices for Monitoring Patient Glucose Levels


  Optical Devices for Monitoring Patient Glucose Levels

  PGM377K May 2022 • US$2,850 


 

 

Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their patients. Signal processing improvements – include improved signal-to-noise ratios and interference filtering – will continue to be critical to the commercialization prospects of noninvasive monitors. For patient with chronic conditions monitoring is a way of life, Now the convergence of small-scale electronics and sophisticated biocompatible product designs is providing a better way to manage chronic conditions for patients worldwide. Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing. By integrating the sensing element, electronics, and0 a power source in a single package, noninvasive monitors are creating new options for caregivers and their patients. Signal processing improvements – include improved signal-to-noise ratios and interference filtering – will continue to be critical to the commercialization prospects of noninvasive monitors.

 

monitoring patient glucose levels

 

Optical Devices for Monitoring Patient Glucose Levels – What You Will Learn

• What are the noninvasive sensing and monitoring technologies that are being pursued, who are the players behind them, and what is their development status?
• What are the key noninvasive optical monitoring device design issues and evolving market factors?
• What is the global market potential for optical monitors today? What will it be in 2024?
• What will be the likely impact of the availability of commercial noninvasive sensing technology and devices on disease management markets?
• Who are the market participants in the noninvasive monitoring sector? What are their technologies, product development activities and business strategies?
• What will be the impact of economic, technology, and regulatory factors on the commercial potential of optical device patient monitors?

 

Summary of Contents

Executive Summary
Glucose Sensing Market Overview
Monitoring Glucose Levels
Key Factors in Patient Compliance
Market Drivers
Industry Alignment and Competitive Landscape
Noninvasive Glucose Measurement Design Factors
Measuring Glucose in Interstitial Fluid
Patient/User Interface
Reliability
Data Collection & Reporting
Commercial Track NGM Technologies
Spectroscopy
Raman
Infrared
Reverse Iontophoresis
Continuous Glucose Monitoring
Near-term Noninvasive Glucose Measurement Device Analysis
Optical Data Collection
Direct Analyte Measurement
Multimode Sensing
Forecasts
Important Private Research Programs
Asia
Soompo Japan Research Institute
Toyama Medical And Pharmaceutical University (Japan)
North America
Juvenile Diabetes Research Foundation (USA)
Juvenile Diabetes Research Foundation (USA)
Europe
Medical University of Graz (Austria)
Medical Research Foundation (The Netherlands)
Commercialization Factors
Calibration Frequency
Accuracy & Precision
Sensitivity
Sensor Technology & Signal Processing Advances
Market Factors
Regulations
FDA
EMEA
Asia (Japan)
Clinical Trials
Company Profiles